Katri Abel-Ollo
Overview
Explore the profile of Katri Abel-Ollo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
176
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Giraudon I, Abel-Ollo K, Vanaga-Araja D, Heudtlass P, Griffiths P
Lancet Public Health
. 2024 Feb;
9(4):e216.
PMID: 38408464
No abstract available.
2.
McDonald R, Eide D, Abel-Ollo K, Barnsdale L, Carter B, Clausen T, et al.
Int J Drug Policy
. 2022 Jul;
107:103787.
PMID: 35849935
Background: In March 2020, the World Health Organization declared COVID-19 a global pandemic. In the following weeks, most European countries implemented national lockdowns to mitigate viral spread. Services for people...
3.
4.
McDonald R, Breidahl S, Abel-Ollo K, Akhtar S, Clausen T, Day E, et al.
Eur Addict Res
. 2022 Feb;
28(3):220-225.
PMID: 35114666
Background: Injectable naloxone is already provided as take-home naloxone (THN), and new concentrated intranasal naloxone is now being introduced in Europe. Despite evidence of the effectiveness and cost-effectiveness of THN,...
5.
Huik K, Avi R, Pauskar M, Kallas E, Jogeda E, Karki T, et al.
PLoS One
. 2016 Jun;
11(6):e0156850.
PMID: 27304910
Objective: The role of CC chemokine receptor 5 (CCR5) and its ligand CCL5 on the pathogenesis of HIV infection has been well studied but not for HCV infection. Here, we...
6.
Burke S, Calabrese S, Dovidio J, Levina O, Uuskula A, Niccolai L, et al.
Soc Sci Med
. 2015 Feb;
130:154-61.
PMID: 25703668
Experiences of stigma are often associated with negative mental and physical health outcomes. The present work tested the associations between stigma and health-related outcomes among people with HIV who inject...
7.
Huik K, Avi R, Uibopuu H, Pauskar M, Margus T, Karki T, et al.
J Acquir Immune Defic Syndr
. 2014 Feb;
66(3):239-44.
PMID: 24508837
Background: The influence of the diversity of CCR5 on HIV susceptibility and disease progression has been clearly demonstrated but how the variability of this gene influences the HIV tropism is...
8.
Ruutel K, Karnite A, Talu A, Abel-Ollo K, Kirvelaite G, Kliiman K, et al.
Int J Drug Policy
. 2013 Nov;
25(1):175-8.
PMID: 24210296
Background: Illegal drug use and HIV are independent risk factors for tuberculosis (TB) among injecting drug users (IDU). Estonia and Latvia have experienced high rates of TB as well as...
9.
Huik K, Avi R, Carrillo A, Harper N, Pauskar M, Sadam M, et al.
PLoS One
. 2013 Aug;
8(7):e70561.
PMID: 23936229
Background: Up to 90% HIV-1 positive intravenous drug users (IDUs) are co-infected with HCV. Although best recognized for its function as a major co-receptor for cell entry of HIV, CC...
10.
Uuskula A, Rajaleid K, Talu A, Abel-Ollo K, Des Jarlais D
Int J Drug Policy
. 2013 Jan;
24(4):312-8.
PMID: 23290632
Aims: Here we report a study aimed at estimating trends in the prevalence of injection drug use between 2005 and 2009 in Estonia. Background: Descriptions of behavioural epidemics have received...